On the public citation graph

Frontrunners in the race to develop a SARS-CoV-2 vaccine

https://doi.org/10.1139/cjm-2020-0465

0 signed · 180 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.2020.15543openalex-snapshot

Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes

inferredcites →https://doi.org/10.1001/jama.2020.6775openalex-snapshot

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

inferredcites →https://doi.org/10.1002/9781118870914.ch2openalex-snapshot

The Production of Plasmid DNA Vaccine inEscherichia coli: A Novel Bacterial‐Based Vaccine Production Platform

inferredcites →https://doi.org/10.1002/9781119086512.ch28openalex-snapshot

Principles of Vaccination

inferredcites →https://doi.org/10.1002/bit.21172openalex-snapshot

The IE2 promoter/enhancer region from mouse CMV provides high levels of therapeutic protein expression in mammalian cells

inferredcites →https://doi.org/10.1002/bmb.21360openalex-snapshot

Insights from 20 years of the Molecule of the Month

inferredcites →https://doi.org/10.1002/cmdc.201200487openalex-snapshot

Modern Subunit Vaccines: Development, Components, and Research Opportunities

inferredcites →https://doi.org/10.1002/jmv.23546openalex-snapshot

Seroprevalence of neutralizing antibodies to human adenoviruses type‐5 and type‐26 and chimpanzee adenovirus type‐68 in healthy Chinese adults

inferredcites →https://doi.org/10.1002/path.1570openalex-snapshot

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

inferredcites →https://doi.org/10.1002/path.1700290106openalex-snapshot

Immunological notes. XVII–XXIV

inferredcites →https://doi.org/10.1002/rmv.405openalex-snapshot

Antibody‐dependent enhancement of viral infection: molecular mechanisms and in vivo implications

inferredcites →https://doi.org/10.1006/viro.1996.0239openalex-snapshot

A Replication-Defective Human Adenovirus Recombinant Serves as a Highly Efficacious Vaccine Carrier

inferredcites →https://doi.org/10.1007/82_2020_217openalex-snapshot

Formulation and Delivery Technologies for mRNA Vaccines

inferredcites →https://doi.org/10.1007/978-1-4939-2438-7openalex-snapshot

Coronaviruses

inferredcites →https://doi.org/10.1007/978-1-4939-2438-7_1openalex-snapshot

Coronaviruses: An Overview of Their Replication and Pathogenesis

inferredcites →https://doi.org/10.1016/0008-8749(89)90011-7openalex-snapshot

Different T helper cell subsets elicited in mice utilizing two different adjuvant vehicles: The role of endogenous interleukin 1 in proliferative responses

inferredcites →https://doi.org/10.1016/b978-0-12-375156-0.00011-4openalex-snapshot

Vaccines and Vaccination

inferredcites →https://doi.org/10.1016/j.bbrc.2014.07.090openalex-snapshot

Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins

inferredcites →https://doi.org/10.1016/j.bcp.2016.05.001openalex-snapshot

Vaccine technologies: From whole organisms to rationally designed protein assemblies

inferredcites →https://doi.org/10.1016/j.cell.2020.02.052openalex-snapshot

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

inferredcites →https://doi.org/10.1016/j.cell.2020.03.045openalex-snapshot

Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

inferredcites →https://doi.org/10.1016/j.cell.2020.06.008openalex-snapshot

Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2

inferredcites →https://doi.org/10.1016/j.cell.2020.06.011openalex-snapshot

A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies

inferredcites →https://doi.org/10.1016/j.cell.2021.01.037openalex-snapshot

Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity

inferredcites →https://doi.org/10.1016/j.chom.2016.01.007openalex-snapshot

Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice

inferredcites →https://doi.org/10.1016/j.chom.2020.03.023openalex-snapshot

Infection and Rapid Transmission of SARS-CoV-2 in Ferrets

inferredcites →https://doi.org/10.1016/j.immuni.2020.03.007openalex-snapshot

SARS-CoV-2 Vaccines: Status Report

inferredcites →https://doi.org/10.1016/j.immuni.2020.05.002openalex-snapshot

Immunology of COVID-19: Current State of the Science

inferredcites →https://doi.org/10.1016/j.vaccine.2008.09.026openalex-snapshot

A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial

inferredcites →https://doi.org/10.1016/j.vaccine.2009.03.080openalex-snapshot

Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan Children, in the context of vaccine vector efficacy

inferredcites →https://doi.org/10.1016/j.vaccine.2014.04.016openalex-snapshot

Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice

inferredcites →https://doi.org/10.1016/j.vaccine.2019.10.102openalex-snapshot

A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime – MVA85A boost in healthy UK adults

inferredcites →https://doi.org/10.1016/j.virol.2004.03.047openalex-snapshot

Complete nucleotide sequences and genome organization of four chimpanzee adenoviruses

inferredcites →https://doi.org/10.1016/j.ygeno.2020.04.016openalex-snapshot

Genotyping coronavirus SARS-CoV-2: methods and implications

inferredcites →https://doi.org/10.1016/j.ymthe.2004.07.013openalex-snapshot

Adenoviruses as vaccine vectors

inferredcites →https://doi.org/10.1016/j.ymthe.2017.03.035openalex-snapshot

Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses

inferredcites →https://doi.org/10.1016/j.ymthe.2017.11.017openalex-snapshot

Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses

inferredcites →https://doi.org/10.1016/s0140-6736(03)14962-8openalex-snapshot

Effects of a SARS-associated coronavirus vaccine in monkeys

inferredcites →https://doi.org/10.1016/s0140-6736(20)30183-5openalex-snapshot

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

inferredcites →https://doi.org/10.1016/s0140-6736(20)30211-7openalex-snapshot

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

inferredcites →https://doi.org/10.1016/s0140-6736(20)30251-8openalex-snapshot

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

inferredcites →https://doi.org/10.1016/s0140-6736(20)30763-7openalex-snapshot

Ensuring global access to COVID-19 vaccines

inferredcites →https://doi.org/10.1016/s0140-6736(20)31208-3openalex-snapshot

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

inferredcites →https://doi.org/10.1016/s0140-6736(20)31604-4openalex-snapshot

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

inferredcites →https://doi.org/10.1016/s0140-6736(20)31605-6openalex-snapshot

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

inferredcites →https://doi.org/10.1016/s0140-6736(20)31866-3openalex-snapshot

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

inferredcites →https://doi.org/10.1016/s1473-3099(19)30266-xopenalex-snapshot

Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial

inferredcites →https://doi.org/10.1016/s1473-3099(20)30120-1openalex-snapshot

An interactive web-based dashboard to track COVID-19 in real time

inferredcites →https://doi.org/10.1016/s1473-3099(20)30709-xopenalex-snapshot

The arrival of Sputnik V

inferredcites →https://doi.org/10.1016/s1473-3099(20)30831-8openalex-snapshot

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

inferredcites →https://doi.org/10.1016/s1473-3099(20)30843-4openalex-snapshot

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

inferredcites →https://doi.org/10.1038/415331aopenalex-snapshot

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

inferredcites →https://doi.org/10.1038/mt.2012.223openalex-snapshot

ChAd63-MVA–vectored Blood-stage Malaria Vaccines Targeting MSP1 and AMA1: Assessment of Efficacy Against Mosquito Bite Challenge in Humans

inferredcites →https://doi.org/10.1038/mt.2013.284openalex-snapshot

Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens

inferredcites →https://doi.org/10.1038/nature02463openalex-snapshot

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

inferredcites →https://doi.org/10.1038/nature21428openalex-snapshot

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

inferredcites →https://doi.org/10.1038/nm1024openalex-snapshot

Identification of a new human coronavirus

inferredcites →https://doi.org/10.1038/nrd.2017.243openalex-snapshot

mRNA vaccines — a new era in vaccinology

inferredcites →https://doi.org/10.1038/nrd2224openalex-snapshot

More than one reason to rethink the use of peptides in vaccine design

inferredcites →https://doi.org/10.1038/nri3581openalex-snapshot

Regulation of type I interferon responses

inferredcites →https://doi.org/10.1038/nrmicro3143openalex-snapshot

A decade after SARS: strategies for controlling emerging coronaviruses

inferredcites →https://doi.org/10.1038/s41392-020-0159-1openalex-snapshot

Correction: Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study

inferredcites →https://doi.org/10.1038/s41421-020-00226-1openalex-snapshot

Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical implications in vivo

inferredcites →https://doi.org/10.1038/s41423-020-0377-zopenalex-snapshot

Epitopes for a 2019-nCoV vaccine

inferredcites →https://doi.org/10.1038/s41423-020-0400-4openalex-snapshot

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

inferredcites →https://doi.org/10.1038/s41467-020-16505-0openalex-snapshot

Immunogenicity of a DNA vaccine candidate for COVID-19

inferredcites →https://doi.org/10.1038/s41467-020-20653-8openalex-snapshot

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice

inferredcites →https://doi.org/10.1038/s41541-017-0029-1openalex-snapshot

Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model

inferredcites →https://doi.org/10.1038/s41541-020-00243-xopenalex-snapshot

Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses

inferredcites →https://doi.org/10.1038/s41564-020-0695-zopenalex-snapshot

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

inferredcites →https://doi.org/10.1038/s41577-020-00434-6openalex-snapshot

Immunological considerations for COVID-19 vaccine strategies

inferredcites →https://doi.org/10.1038/s41577-020-0321-6openalex-snapshot

The potential danger of suboptimal antibody responses in COVID-19

inferredcites →https://doi.org/10.1038/s41586-020-2607-zopenalex-snapshot

Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques

inferredcites →https://doi.org/10.1038/s41586-020-2622-0openalex-snapshot

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

inferredcites →https://doi.org/10.1038/s41586-020-2639-4openalex-snapshot

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

inferredcites →https://doi.org/10.1038/s41586-020-2814-7openalex-snapshot

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

inferredcites →https://doi.org/10.1038/s41591-020-1070-6openalex-snapshot

Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters

inferredcites →https://doi.org/10.1038/s41598-017-04547-2openalex-snapshot

Electroporation as a vaccine delivery system and a natural adjuvant to intradermal administration of plasmid DNA in macaques

inferredcites →https://doi.org/10.1038/srep16756openalex-snapshot

Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice

inferredcites →https://doi.org/10.1056/nejmoa1411627openalex-snapshot

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

inferredcites →https://doi.org/10.1056/nejmoa2022483openalex-snapshot

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

inferredcites →https://doi.org/10.1056/nejmoa2024671openalex-snapshot

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

inferredcites →https://doi.org/10.1056/nejmoa2026920openalex-snapshot

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

inferredcites →https://doi.org/10.1056/nejmoa2027906openalex-snapshot

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

inferredcites →https://doi.org/10.1056/nejmoa2028436openalex-snapshot

Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

inferredcites →https://doi.org/10.1056/nejmoa2034201openalex-snapshot

Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine

inferredcites →https://doi.org/10.1073/pnas.1209367109openalex-snapshot

Nonviral delivery of self-amplifying RNA vaccines

inferredcites →https://doi.org/10.1073/pnas.2003138117openalex-snapshot

Cell entry mechanisms of SARS-CoV-2

inferredcites →https://doi.org/10.1080/10409230290771447openalex-snapshot

DNA Vaccine Against Malaria: A Long Way To Go

inferredcites →https://doi.org/10.1080/21645515.2016.1165908openalex-snapshot

Adenoviral vector-based strategies against infectious disease and cancer

inferredcites →https://doi.org/10.1080/21645515.2016.1238535openalex-snapshot

Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia

inferredcites →https://doi.org/10.1084/jem.20071087openalex-snapshot

Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells

inferredcites →https://doi.org/10.1093/cid/ciaa248openalex-snapshot

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China

inferredcites →https://doi.org/10.1093/cid/ciaa325openalex-snapshot

Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility

inferredcites →https://doi.org/10.1093/infdis/jiz070openalex-snapshot

Safety and Immunogenicity of a 2-Dose Heterologous Vaccination Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Uganda and Tanzania

inferredcites →https://doi.org/10.1099/0022-1317-83-3-595openalex-snapshot

Conservation of substrate specificities among coronavirus main proteases

inferredcites →https://doi.org/10.1101/2020.04.10.036418openalex-snapshot

The SARS-CoV-2 Receptor-Binding Domain Elicits a Potent Neutralizing Response Without Antibody-Dependent Enhancement

inferredcites →https://doi.org/10.1101/2020.04.22.055608openalex-snapshot

Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine induces equivalent preclinical antibody titers and viral neutralization to recovered COVID-19 patients

inferredcites →https://doi.org/10.1101/2020.05.13.093195openalex-snapshot

ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques

inferredcites →https://doi.org/10.1101/2020.07.28.225649openalex-snapshot

Intradermal-delivered DNA vaccine provides anamnestic protection in a rhesus macaque SARS-CoV-2 challenge model

inferredcites →https://doi.org/10.1101/2020.07.29.227595openalex-snapshot

A Next Generation Bivalent Human Ad5 COVID-19 Vaccine Delivering Both Spike and Nucleocapsid Antigens Elicits Th1 Dominant CD4+, CD8+ T-cell and Neutralizing Antibody Responses

inferredcites →https://doi.org/10.1101/2020.09.08.280818openalex-snapshot

A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates

inferredcites →https://doi.org/10.1111/all.14238openalex-snapshot

Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China

inferredcites →https://doi.org/10.1111/j.0818-9641.2004.01272.xopenalex-snapshot

Vaccine adjuvants: Current state and future trends

inferredcites →https://doi.org/10.1126/sciadv.aba8399openalex-snapshot

A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques

inferredcites →https://doi.org/10.1126/science.abb2507openalex-snapshot

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

inferredcites →https://doi.org/10.1126/science.abb2762openalex-snapshot

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

inferredcites →https://doi.org/10.1126/science.abb7015openalex-snapshot

Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2

inferredcites →https://doi.org/10.1126/science.abb8923openalex-snapshot

Rapid COVID-19 vaccine development

inferredcites →https://doi.org/10.1126/science.abc1932openalex-snapshot

Development of an inactivated vaccine candidate for SARS-CoV-2

inferredcites →https://doi.org/10.1126/science.abc4776openalex-snapshot

SARS-CoV-2 infection protects against rechallenge in rhesus macaques

inferredcites →https://doi.org/10.1126/science.abc6027openalex-snapshot

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

inferredcites →https://doi.org/10.1126/science.abc6284openalex-snapshot

DNA vaccine protection against SARS-CoV-2 in rhesus macaques

inferredcites →https://doi.org/10.1126/science.abe5960openalex-snapshot

Will SARS-CoV-2 become endemic?

inferredcites →https://doi.org/10.1126/scitranslmed.3009185openalex-snapshot

A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory

inferredcites →https://doi.org/10.1126/scitranslmed.aac7462openalex-snapshot

A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates

inferredcites →https://doi.org/10.1128/cdli.11.2.351-357.2004openalex-snapshot

Prevalence of Neutralizing Antibodies to Adenoviral Serotypes 5 and 35 in the Adult Populations of The Gambia, South Africa, and the United States

inferredcites →https://doi.org/10.1128/cmr.00084-18openalex-snapshot

Factors That Influence the Immune Response to Vaccination

inferredcites →https://doi.org/10.1128/iai.69.3.1643-1649.2001openalex-snapshot

Interleukin-12- and Gamma Interferon-Dependent Protection against Malaria Conferred by CpG Oligodeoxynucleotide in Mice

inferredcites →https://doi.org/10.1128/jvi.00671-11openalex-snapshot

Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent FcγR Pathway

inferredcites →https://doi.org/10.1128/jvi.01782-06openalex-snapshot

Severe Acute Respiratory Syndrome Coronavirus Open Reading Frame (ORF) 3b, ORF 6, and Nucleocapsid Proteins Function as Interferon Antagonists

inferredcites →https://doi.org/10.1128/jvi.02407-10openalex-snapshot

Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge

inferredcites →https://doi.org/10.1128/jvi.64.3.1407-1409.1990openalex-snapshot

Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization

inferredcites →https://doi.org/10.1128/jvi.66.2.956-965.1992openalex-snapshot

Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages

inferredcites →https://doi.org/10.1128/jvi.70.7.4805-4810.1996openalex-snapshot

Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli

inferredcites →https://doi.org/10.1128/jvi.71.3.1842-1849.1997openalex-snapshot

Construction of adenovirus vectors through Cre-lox recombination

inferredcites →https://doi.org/10.1128/jvi.77.13.7663-7668.2003openalex-snapshot

Vaccine-Induced Immunity in Baboons by Using DNA and Replication-Incompetent Adenovirus Type 5 Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

inferredcites →https://doi.org/10.1128/jvi.79.2.884-895.2005openalex-snapshot

Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia

inferredcites →https://doi.org/10.1128/jvi.79.24.15107-15113.2005openalex-snapshot

Humoral and Cellular Immune Response to RNA Immunization with Flavivirus Replicons Derived from Tick-Borne Encephalitis Virus

inferredcites →https://doi.org/10.1136/jitc-2020-000928openalex-snapshot

Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial

inferredcites →https://doi.org/10.1146/annurev.immunol.18.1.927openalex-snapshot

DNA Vaccines: Immunology, Application, and Optimization

inferredcites →https://doi.org/10.1155/2015/616898openalex-snapshot

Comparison ofβ-Propiolactone and Formalin Inactivation on Antigenicity and Immune Response of West Nile Virus

inferredcites →https://doi.org/10.1155/2015/794528openalex-snapshot

RNA-Based Vaccines in Cancer Immunotherapy

inferredcites →https://doi.org/10.1159/000494034openalex-snapshot

Extracellular RNA Sensing by Pattern Recognition Receptors

inferredcites →https://doi.org/10.1164/arrd.1972.105.5.805openalex-snapshot

Coronavirus infections in working adults. Eight-year study with 229 E and OC 43.

inferredcites →https://doi.org/10.1172/jci126363openalex-snapshot

IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes

inferredcites →https://doi.org/10.1177/135965350701200702openalex-snapshot

Safety and Immunogenicity from a Phase I Trial of Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine

inferredcites →https://doi.org/10.1182/blood-2006-08-040691openalex-snapshot

Extracellular RNA mediates endothelial-cell permeability via vascular endothelial growth factor

inferredcites →https://doi.org/10.1186/1475-2859-11-107openalex-snapshot

Development of new plasmid DNA vaccine vectors with R1-based replicons

inferredcites →https://doi.org/10.1186/s12865-017-0196-xopenalex-snapshot

Immunogenicity and therapeutic effects of a Mycobacterium tuberculosis rv2190c DNA vaccine in mice

inferredcites →https://doi.org/10.1186/s12879-020-05681-5openalex-snapshot

Correlation analysis between disease severity and inflammation-related parameters in patients with COVID-19: a retrospective study

inferredcites →https://doi.org/10.1186/s13046-019-1154-7openalex-snapshot

Cancer DNA vaccines: current preclinical and clinical developments and future perspectives

inferredcites →https://doi.org/10.1358/dot.2018.54.5.2807864openalex-snapshot

Plasmid DNA vaccines: where are we now?

inferredcites →https://doi.org/10.1371/journal.pone.0035421openalex-snapshot

Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus

inferredcites →https://doi.org/10.1371/journal.pone.0040385openalex-snapshot

A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity

inferredcites →https://doi.org/10.1371/journal.pone.0045842openalex-snapshot

Lack of Innate Interferon Responses during SARS Coronavirus Infection in a Vaccination and Reinfection Ferret Model

inferredcites →https://doi.org/10.1371/journal.pone.0057755openalex-snapshot

Risk in Vaccine Research and Development Quantified

inferredcites →https://doi.org/10.1371/journal.pone.0101591openalex-snapshot

Safety and Tolerability of Conserved Region Vaccines Vectored by Plasmid DNA, Simian Adenovirus and Modified Vaccinia Virus Ankara Administered to Human Immunodeficiency Virus Type 1-Uninfected Adults in a Randomized, Single-Blind Phase I Trial

inferredcites →https://doi.org/10.1385/1592596886openalex-snapshot

DNA Vaccines

inferredcites →https://doi.org/10.1517/14712598.4.8.1285openalex-snapshot

Messenger RNA-based vaccines

inferredcites →https://doi.org/10.1586/erv.09.43openalex-snapshot

SARS vaccines: where are we?

inferredcites →https://doi.org/10.1586/erv.12.38openalex-snapshot

Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges

inferredcites →https://doi.org/10.21775/cimb.022.079openalex-snapshot

DNA Vaccines: Regulatory Considerations and Safety Aspects

inferredcites →https://doi.org/10.2217/fvl-2016-0070openalex-snapshot

Simian Adenoviruses As Vaccine Vectors

inferredcites →https://doi.org/10.24171/j.phrp.2020.11.1.02openalex-snapshot

Identification of Coronavirus Isolated from a Patient in Korea with COVID-19

inferredcites →https://doi.org/10.3389/fimmu.2013.00354openalex-snapshot

Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants

inferredcites →https://doi.org/10.3389/fimmu.2018.01963openalex-snapshot

New Vaccine Technologies to Combat Outbreak Situations

inferredcites →https://doi.org/10.3389/fimmu.2019.00594openalex-snapshot

Advances in mRNA Vaccines for Infectious Diseases

inferredcites →https://doi.org/10.3390/vaccines2010138openalex-snapshot

DNA Immunization for HIV Vaccine Development

inferredcites →https://doi.org/10.3390/vaccines3020320openalex-snapshot

Vaccine Adjuvants: from 1920 to 2015 and Beyond

inferredcites →https://doi.org/10.3390/vaccines6020020openalex-snapshot

New Kids on the Block: RNA-Based Influenza Virus Vaccines

inferredcites →https://doi.org/10.4049/jimmunol.170.3.1416openalex-snapshot

A Simian Replication-Defective Adenoviral Recombinant Vaccine to HIV-1 Gag

inferredcites →https://doi.org/10.7554/elife.52687openalex-snapshot

Squalene emulsion-based vaccine adjuvants stimulate CD8 T cell, but not antibody responses, through a RIPK3-dependent pathway

inferredcites →https://doi.org/10.7554/elife.61312openalex-snapshot

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

inferredcites →https://doi.org/10.7717/peerj.9255openalex-snapshot

Insights on early mutational events in SARS-CoV-2 virus reveal founder effects across geographical regions

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3973422openalex-extracted

Projeto S: A Stepped-Wedge Randomized Trial to Assess CoronaVac Effectiveness in Serrana, Brazil

inferred← citeshttps://doi.org/10.1007/978-3-030-85113-2_2openalex-snapshot

Outbreak of COVID-19: A Detailed Overview and Its Consequences

inferred← citeshttps://doi.org/10.1007/s11696-023-02795-3openalex-snapshot

Superior possibilities and upcoming horizons for nanoscience in COVID-19: noteworthy approach for effective diagnostics and management of SARS-CoV-2 outbreak

inferred← citeshttps://doi.org/10.1016/j.cellin.2022.100029openalex-snapshot

Emerging SARS-CoV-2 variants: Why, how, and what's next?

inferred← citeshttps://doi.org/10.1016/j.compbiomed.2022.105814openalex-snapshot

Identification of a novel immune-inflammatory signature of COVID-19 infections, and evaluation of pharmacokinetics and therapeutic potential of RXn-02, a novel small-molecule derivative of quinolone

inferred← citeshttps://doi.org/10.1016/j.intimp.2021.108021openalex-snapshot

Administration of COVID-19 vaccines in immunocompromised patients

inferred← citeshttps://doi.org/10.1038/s41598-026-37815-1openalex-snapshot

Indirect protection and long-term effectiveness of inactivated COVID-19 vaccine: a stepped-wedge randomised trial in Serrana, Brazil

inferred← citeshttps://doi.org/10.1101/2025.05.28.25328470openalex-snapshot

Post-vaccination chemosensory outcomes in COVID-19-associated dysfunction

inferred← citeshttps://doi.org/10.1128/msphere.00998-21openalex-snapshot

Adenovirus 5 Vectors Expressing SARS-CoV-2 Proteins

inferred← citeshttps://doi.org/10.3389/fddsv.2022.927164openalex-snapshot

Nanobodies: COVID-19 and Future Perspectives

inferred← citeshttps://doi.org/10.3389/fdgth.2021.745674openalex-snapshot

Vaccine Development in the Time of COVID-19: The Relevance of the Risklick AI to Assist in Risk Assessment and Optimize Performance

inferred← citeshttps://doi.org/10.3390/cells11020253openalex-snapshot

Calcium Signals during SARS-CoV-2 Infection: Assessing the Potential of Emerging Therapies

inferred← citeshttps://doi.org/10.3390/vaccines9121383openalex-snapshot

Receptor-Binding Domain Proteins of SARS-CoV-2 Variants Elicited Robust Antibody Responses Cross-Reacting with Wild-Type and Mutant Viruses in Mice

inferred← citeshttps://doi.org/10.52586/4931openalex-snapshot

A detailed review of the outbreak of COVID-19

inferred← citeshttps://doi.org/10.5958/0974-0147.2021.00002.7openalex-snapshot

Role of syrian hamsters and nonhuman primates in covid-19 research

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.